Foster Victor Wealth Advisors’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.4M | Buy |
394,595
+3,390
| +0.9% | +$184K | 1.33% | 15 |
|
|
2025
Q4 | $18.9M | Buy |
391,205
+5,733
| +1% | +$267K | 1.1% | 25 |
|
|
2025
Q3 | $16.7M | Buy |
385,472
+21,778
| +6% | +$851K | 1.04% | 38 |
|
|
2025
Q2 | $14.2M | Buy |
363,694
+11,383
| +3% | +$435K | 0.96% | 45 |
|
|
2025
Q1 | $12.2M | Buy |
352,311
+51
| +0% | +$1.87K | 0.98% | 48 |
|
|
2024
Q4 | $11.8M | Buy |
352,260
+79,343
| +29% | +$2.86M | 0.9% | 52 |
|
|
2024
Q3 | $11M | Buy |
272,917
+13,045
| +5% | +$534K | 0.88% | 51 |
|
|
2024
Q2 | $10.1M | Buy |
259,872
+43,422
| +20% | +$1.83M | 0.84% | 51 |
|
|
2024
Q1 | $8.83M | Buy |
216,450
+66,632
| +44% | +$2.75M | 0.81% | 60 |
|
|
2023
Q4 | $5.94M | Buy |
149,818
+5,818
| +4% | +$209K | 0.61% | 61 |
|
|
2023
Q3 | $5.28M | Buy |
144,000
+4,034
| +3% | +$143K | 0.61% | 62 |
|
|
2023
Q2 | $4.86M | Buy |
139,966
+7,588
| +6% | +$272K | 0.54% | 64 |
|
|
2023
Q1 | $4.84M | Buy |
132,378
+6,372
| +5% | +$223K | 0.59% | 60 |
|
|
2022
Q4 | $4.4M | Sell |
126,006
-535
| -0.4% | -$17.8K | 0.56% | 63 |
|
|
2022
Q3 | $3.8M | Buy |
126,541
+32,612
| +35% | +$1.24M | 0.55% | 63 |
|
|
2022
Q2 | $5.06M | Buy |
93,929
+1,908
| +2% | +$105K | 0.75% | 56 |
|
|
2022
Q1 | $5.26M | Buy |
92,021
+12,296
| +15% | +$668K | 0.72% | 56 |
|
|
2021
Q4 | $4.51M | Buy |
79,725
+14,737
| +23% | +$767K | 0.61% | 61 |
|
|
2021
Q3 | $3.1M | Buy |
64,988
+9,905
| +18% | +$498K | 0.5% | 62 |
|
|
2021
Q2 | $2.74M | Buy |
55,083
+15,027
| +38% | +$722K | 0.46% | 70 |
|
|
2021
Q1 | $1.8M | Buy |
40,056
+19,064
| +91% | +$865K | 0.34% | 80 |
|
|
2020
Q4 | $966K | Buy |
20,992
+9,702
| +86% | +$446K | 0.22% | 84 |
|
|
2020
Q3 | $531K | Buy |
11,290
+6,254
| +124% | +$313K | 0.14% | 92 |
|
|
2020
Q2 | $257K | Buy |
+5,036
| New | +$258K | 0.09% | 103 |
|
Other funds holding GSK
JEST